TBET — Tibet Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Tibet Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2008 December 31st | 2009 December 31st | 2010 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 2.71 | 4.08 | 7.58 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 3.08 | 4.71 | 12.4 |
| Total Inventory | |||
| Total Other Current Assets | |||
| Total Current Assets | 7.22 | 10.2 | 21.1 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 7.23 | 6.55 | 6.17 |
| Net Intangible Assets | |||
| Other Long Term Assets | |||
| Total Assets | 16 | 18 | 28.2 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Current Liabilities | 2.34 | 3.83 | 4.71 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 5.91 | 7.42 | 4.71 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | 10.1 | 10.5 | 23.5 |
| Total Liabilities & Shareholders' Equity | 16 | 18 | 28.2 |
| Total Common Shares Outstanding |